High incidence of antifungal drug resistance in Candida tropicalis (Q47628637)

4 February 2018

title

High incidence of antifungal drug resistance in Candida tropicalis (English)

1 reference

4 February 2018

antifungal drug resistance

main subject

1 reference

Candida tropicalis

1 reference

5

1 reference

4 February 2018

author name string

Law D

1

1 reference

4 February 2018

Moore CB

2

1 reference

4 February 2018

Joseph LA

3

1 reference

4 February 2018

Keaney MG

4

1 reference

4 February 2018

publication date

1 October 1996

1 reference

4 February 2018

International Journal of Antimicrobial Agents

published in

1 reference

4 February 2018

volume

7

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

241-245

1 reference

4 February 2018

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. Working party of the British Society for Antimicrobial Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Resistance of yeasts to azole-derivative antifungals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Can we prevent azole resistance in fungi?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Fluconazole-resistant candidosis in an HIV cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

An analysis of the trends in the use of antifungal drugs and fungal isolates in a UK University Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

Predictive value of surveillance cultures for systemic infection due to Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

The value of fungal surveillance cultures as predictors of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900328-7

7 January 2021

10.1016/S0924-8579(96)00328-7

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018